1. A system for confirming identity and authority by a patient medical device, comprising:
master credentials issued to a requesting device and an implantable medical device from an authorizing agent comprising a public key of the authorizing agent, a public key of a verification agent, and a digital signature of a root certification authority;
device credentials issued to the requesting device from the authorizing agent comprising a public key of the requesting device and a digital signature of the authorizing agent;
short-term authorization credentials issued to the requesting device from the verification agent comprising a digital signature of the verification agent, the short-term authorization credentials including an expiration date;
access credentials provided to the implantable medical device, the access credentials comprising the device credentials, the short-term authorization credentials, and a digital signature of the requesting device; and
an authentication module configured to authenticate the requesting device, comprising:
a device credential module configured to check the digital signature of the authorizing agent in the device credentials using the public key of the authorizing agent in the master credentials of the implantable medical device; and
an identification credential module configured to check the digital signature of the requesting device in the access credentials using the public key of the requesting device in the device credentials; and
an authorization credentials module configured to check the digital signature of the verification agent in the short term authorization credentials using the public key of the verification agent in the master credentials of the implantable medical device and verify that the expiration date has not passed; and
a reauthorization module to get updated short term authorization credentials from the verification agent with an updated expiration date.
2. A system according to claim 1, wherein one of interrogation and programming of the implantable medical device are permitted upon successful authentication of the requesting device.
3. A system according to claim 1, further comprising:
at least one of permissions, limits, and restrictions on the requesting device included in the authorization credentials, wherein the at least one permission, limit, and restriction in the access credentials are checked.
4. A system according to claim 3, wherein the at least one permission, limit, and restriction is selected from the group comprising a limit on a number of sessions, set of permitted operations, and set of prohibited operations.
5. A system according to claim 3, wherein one of interrogation and programming of the implantable medical device within the at least one permission, limit, and restriction are permitted upon successful authentication of the requesting device.
6. A system according to claim 1, wherein the master credentials, further master credentials, device credentials, and authorization credentials comprise digital asymmetric public and private key pairs.
7. A system according to claim 1, further comprising:
a chain of trust, comprising a root certification authority, wherein the trust is delegated to one or more further certification authorities from the root certification authority.
8. A system according to claim 7, wherein the chain of trust is structured as a hierarchy and the further certification authorities inherit the trust from the root certification authority.
9. A system according to claim 1, wherein the requesting device is selected from the group comprising a programmer and a personal communicator, each of which can interrogate or program, the implantable medical device using long range telemetry.
10. A system according to claim 1, wherein the implantable medical device comprises a device selected from the group comprising a pacemaker, implantable cardioverter-defibrillator, and cardiac synchronization therapy device.
11. A method for confirming identity and authority by a patient medical device, comprising:
issuing master credentials to a requesting device and a implantable medical device from an authorizing agent comprising a public key of the authorizing agent, a public key of a verification agent, and a digital signature of a root certification authority;
issuing device credentials to the requesting device from the authorizing agent comprising a public key of the requesting device and a digital signature of the authorizing agent;
issuing short-term authorization credentials to the requesting device from the verification agent comprising a digital signature of the verification agent, the short-term authorization credentials including an expiration date;
providing access credentials to the implantable medical device, the access credentials comprising the device credentials, the short-term authorization credentials, and a digital signature of the requesting device; and
authenticating the requesting device, comprising:
checking the digital signature of the authorizing agent in the device credentials using the public key of the authorizing agent in the master credentials of the implantable medical device
checking the digital signature of the requesting device in the access credentials using the public key of the requesting device in the device credentials;
checking the digital signature of the verification agent in the short-term authorization credentials using the public key of the verification agent in the master credentials of the implantable medical device and verifying that the expiration date has not passed; and
getting updated short-term authorization credentials from the verification agent with an updated expiration date.
12. A method according to claim 11, further comprising:
permitting one of interrogation and programming of the implantable medical device upon successful authentication of the requesting device.
13. A method according to claim 11, further comprising:
including at least one of permissions, limits, and restrictions on the requesting device in the authorization credentials; and
checking the at least one permission, limit, and restriction in the access credentials.
14. A method according to claim 13, wherein the at least one permission, limit, and restriction is selected from the group comprising a limit on a number of sessions, set of permitted operations, and set of prohibited operations.
15. A method according to claim 13, further comprising:
permitting one of interrogation and programming of the implantable medical device within the at least one permission, limit, and restriction upon successful authentication of the requesting device.
16. A method according to claim 11, wherein the master credentials, further master credentials, device credentials, and authorization credentials comprise digital asymmetric public and private key pairs.
17. A method according to claim 11, further comprising:
defining a chain of trust, comprising a root certification authority; and
delegating the trust to one or more further certification authorities from the root certification authority.
18. A method according to claim 17, further comprising:
structuring the chain of trust as a hierarchy, wherein the further certification authorities inherit the trust from the root certification authority.
19. A method according to claim 11, wherein the requesting device is selected from the group comprising a programmer and a personal communicator, each of which can interrogate or program the receiving device using long range telemetry.
20. A method according to claim 11, wherein the implantable medical device comprises a device selected from the group comprising a pacemaker, implantable cardioverter-defibrillator, and cardiac resynchronization therapy device.
The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.
1. A compound of formulae (111) to (116), wherein the aromatic systems are each optionally substituted by one or more radicals R1:
wherein
R1 are on each occurrence, identically or differently, H, D, F, Cl, Br, I, N(Ar4)2, C(\u2550O)Ar4, P(\u2550O)(Ar4)2, S(\u2550O)Ar4, S(\u2550O)2Ar4, CR2\u2550CR2Ar4, CHO, CR3\u2550C(R3)2, CN, NO2, Si(R3)3, B(OR3)2, B(R3)2, B(N(R3)2)2, OSO2R3, a straight-chain alkyl, alkoxy or thioalkoxy group having 1 to 40 C atoms or a straight-chain alkenyl or alkynyl group having 2 to 40 C atoms or a branched or cyclic alkyl, alkenyl, alkynyl, alkoxy or thioalkoxy group having 3 to 40 C atoms, each of which are optionally substituted by one or more radicals R3, where in each case one or more non-adjacent CH2 groups are optionally replaced by R3C\u2550CR3, C\u2261C, Si(R3)2, Ge(R3)2, Sn(R3)2, C\u2550O, C\u2550S, C\u2550Se, C\u2550NR3, P(\u2550O)R3, SO, SO2, NR3, O, S or CONR3 and where one or more H atoms are optionally replaced by F, Cl, Br, I, CN or NO2, or an aromatic or heteroaromatic ring system having 5 to 60 aromatic ring atoms, which in each case are optionally substituted by one or more radicals R3, or a combination of these systems;
R2 is on each occurrence, identically or differently, H, D, F, Cl, Br, I, N(Ar4)2, C(\u2550O)Ar4, P(\u2550O)(Ar4)2, S(\u2550O)Ar4, S(\u2550O)2Ar4, CR2\u2550CR2Ar4, CHO, CR3\u2550C(R3)2, CN, NO2, Si(R3)3, B(OR3)2, B(R3)2, B(N(R3)2)2, OSO2R3, a straight-chain alkyl, alkoxy or thioalkoxy group having 1 to 40 C atoms or a straight-chain alkenyl or alkynyl group having 2 to 40 C atoms or a branched or cyclic alkyl, alkenyl, alkynyl, alkoxy or thioalkoxy group having 3 to 40 C atoms, each of which are optionally substituted by one or more radicals R3, where in each case one or more non-adjacent CH2 groups are optionally replaced by R3C\u2550CR3, C\u2261C, Si(R3)2, Ge(R3)2, Sn(R3)2, C\u2550O, C\u2550S, C\u2550Se, C\u2550NR3, P(\u2550O)R3, SO, SO2, NR3, O, S or CONR3 and where one or more H atoms are optionally replaced by F, Cl, Br, I, CN or NO2, or an aromatic or heteroaromatic ring system having 5 to 60 aromatic ring atoms, which in each case are optionally substituted by one or more radicals R3, or a combination of these systems; and wherein two or more substituents R2 optionally define a mono- or polycyclic, aliphatic or aromatic ring system with one another;
Ar4 is on each occurrence, identically or differently, an aromatic or heteroaromatic ring system having 5-30 aromatic ring atoms optionally substituted by one or more non-aromatic radicals R1; and wherein two radicals Ar on the same nitrogen or phosphorus atom are optionally linked to one another by a single bond or a bridge X;
X is on each occurrence, identically or differently, a group selected from BR2, C(R2)2, Si(R2)2, C=O, C=NR2, C=C(R2)2, O, S, S=O, SO2, NR2, PR2, P(=O)R2 and P(=S)R2;
R3 is on each occurrence, identically or differently, H or an aliphatic or aromatic hydrocarbon radical having 1 to 20 C atoms.
2. The compound of claim 1, wherein R1 is selected on each occurrence, identically or differently, from H, D, F, Si(R3)3, straight-chain alkyl or alkoxy groups having 1 to 10 C atoms or branched or cyclic alkyl or alkoxy groups having 3 to 10 C atoms, each of which is optionally substituted by one or more radicals R3, where in each case one or more non-adjacent CH2 groups is optionally replaced by R3C\u2550CR3 or O and where one or more H atoms is optionally replaced by F, or aromatic or heteroaromatic ring systems having 5 to 40 aromatic ring atoms, or a combination of these systems; and wherein two or more substituents R1 optionally define a mono- or polycyclic, aliphatic or aromatic ring system with one another.
3. The compound of claim 1, wherein R2 is selected on each occurrence, identically or differently, from H, straight-chain alkyl groups having 1 to 10 C atoms or branched or cyclic alkyl groups having 3 to 10 C atoms, where in each case one or more non-adjacent CH2 groups are optionally replaced by \u2014R2C\u2550CR2\u2014 or \u2014O\u2014 and where one or more H atoms are optionally replaced by F, or a monovalent aryl or heteroaryl group having 5 to 16 aromatic ring atoms, which is optionally substituted by one or more non-aromatic radicals R2; and wherein two radicals R2 which are bonded to the same C atom optionally define a ring system with one another.
4. An oligomer, polymer, or dendrimer comprising one or more compounds of claim 1, wherein at least one of the radicals R1 andor R2 is a bond to the oligomer, polymer, or dendrimer.
5. An organic electronic device comprising at least one organic layer comprising at least one compound of claim 1.
6. The organic electroluminescent device of claim 5, wherein said compound of claim 1 is employed as emitting material or as host material in an emitting layer or as hole-transport or hole-injection material in a hole-transport or hole-injection layer or as electron-transport material in an electron-transport layer.
7. The organic electroluminescent device of claim 5, wherein said compound of claim 1 is employed as emitting material in an emitting layer in combination with a host material and that the host material is selected from the group consisting of oligoarylenes, oligoarylenes containing condensed aromatic groups, anthracenes, oligoarylenevinylenes, polypodal metal complexes, hole-conducting compounds, electron-conducting compounds, ketones, phosphine oxides, sulfoxides, boronic acid derivatives, benzanthracenes, and compounds of the formula (138),
Ar4\u2014(Ar5)p\u2014Ar6\u2003\u2003formula (138)
wherein Ar4, Ar5, and Ar6 are on each occurrence, identically or differently, an aryl or heteroaryl group having 5 to 30 aromatic ring atoms optionally substituted by one or more radicals R1, and R1 is as defined in claim 1 and p=1; and wherein the sum of their electrons in Ar4, Ar5, and Ar6 is at least 30.
8. A solution or formulation comprising at least one compound of claim 1 and at least one organic solvent.
9. The organic electronic device of claim 5, wherein said device is selected from the group consisting of organic electroluminescent devices, organic field-effect transistors, organic thin-film transistors, organic light-emitting transistors, organic integrated circuits, organic solar cells, organic field-quench devices, light-emitting electrochemical cells, organic photoreceptors, and organic laser diodes.
10. The compound of claim 1, wherein R1 is selected on each occurrence, identically or differently, from H, D, F, Si(R3)3, straight-chain alkyl or alkoxy groups having 1 to 10 C atoms or branched or cyclic alkyl or alkoxy groups having 3 to 10 C atoms, each of which is optionally substituted by one or more radicals R3, where in each case one or more non-adjacent CH2 groups is optionally replaced by R3C\u2550CR3 or O and where one or more H atoms is optionally replaced by F, or aromatic or heteroaromatic ring systems having 5 to 40 aromatic ring atoms, or a combination of these systems, and wherein R2 is selected on each occurrence, identically or differently, from H, straight-chain alkyl groups having 1 to 10 C atoms or branched or cyclic alkyl groups having 3 to 10 C atoms, where in each case one or more non-adjacent CH2 groups are optionally replaced by \u2014R2C\u2550CR2\u2014 or \u2014O\u2014 and where one or more H atoms are optionally replaced by F, or a monovalent aryl or heteroaryl group having 5 to 16 aromatic ring atoms, which is optionally substituted by one or more non-aromatic radicals R2.